Hyep Ivan Insider Trades

Insider Trading History

Track insider trading activity for Hyep Ivan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Financial Officer
Holding Value $1.98M 70,584 shares
Last Trade
May 21, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$192k 9,200 shares
$20.84
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Financial Officer
Holding Value $4.34M 154,555 shares
Last Trade
May 21, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$192k 9,200 shares
$20.84
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Financial Officer
Holding Value $4.08M 145,355 shares
Last Trade
May 21, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$188k 9,200 shares
$20.42
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Financial Officer
Holding Value $4.34M 154,555 shares
Last Trade
Apr 21, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$213k 9,200 shares
$23.11
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Financial Officer
Holding Value $4.08M 145,355 shares
Last Trade
Apr 21, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$212k 9,200 shares
$23.00
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Financial Officer
Holding Value $1.12M 39,744 shares
Last Trade
Apr 21, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$213k 9,200 shares
$23.11
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Financial Officer
Holding Value $1.38M 48,944 shares
Last Trade
Mar 23, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$169k 9,200 shares
$18.39
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Financial Officer
Holding Value $4.34M 154,555 shares
Last Trade
Mar 23, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$169k 9,200 shares
$18.39
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Financial Officer
Holding Value $4.08M 145,355 shares
Last Trade
Mar 23, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$170k 9,200 shares
$18.52
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Financial Officer
Holding Value $4.08M 145,355 shares
Last Trade
Mar 04, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$54.1k 2,963 shares
$18.25
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Financial Officer
Holding Value $2.24M 79,784 shares
Last Trade
Mar 04, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$54.9k 2,963 shares
$18.54
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Financial Officer
Holding Value $4.17M 148,318 shares
Last Trade
Mar 04, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$54.9k 2,963 shares
$18.54
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Financial Officer
Holding Value $4.08M 145,355 shares
Last Trade
Mar 03, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$247k 13,555 shares
$18.22
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Financial Officer
Holding Value $2.33M 82,747 shares
Last Trade
Mar 03, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$243k 13,555 shares
$17.92
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Financial Officer
Holding Value $4.47M 158,910 shares
Last Trade
Mar 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$243k 13,555 shares
$17.92
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Financial Officer
Holding Value $3.51M 125,000 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.1M 125,000 shares
$16.76
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Financial Officer
Holding Value $4.08M 145,355 shares
Last Trade
Jan 22, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$34.2k 1,882 shares
$18.15
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Financial Officer
Holding Value $4.14M 147,237 shares
Last Trade
Jan 22, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$33.1k 1,882 shares
$17.59
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Financial Officer
Holding Value $1.84M 65,462 shares
Last Trade
Jan 22, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$33.1k 1,882 shares
$17.59
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Financial Officer
Holding Value $4.08M 145,355 shares
Last Trade
Dec 22, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$168k 9,200 shares
$18.31
$28.10

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up